20 Dec 2020
Possible Mandatory Unconditional Cash Offer for Shares in Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
Partners Danny Lim and Tan Mui Hui from Rajah & Tann Singapore; and Linda Qiao from Rajah & Tann Shanghai Representative Office are advising Bank of China Limited, Singapore Branch, as joint financial adviser to Jinhushen Biological Medical Science and Technology Co., Ltd and Tianjin Pharmaceutical (Singapore) International Investment Pte. Ltd., as offeror in the possible mandatory unconditional cash offer for shares in Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. Based on the offer price of US$0.893 per Singapore Exchange Securities Trading Limited share and RMB17.43 per Shanghai Stock Exchange share, the company is valued at around S$2.26 billion.